SRM Institute of Science and Technology secures Rs 6.03 Cr ANRF grants
April 17, 2026 | Friday | News
SRMIST is ready to launch a state-of-the-art Research Park
The Directorate of Research, SRM Institute of Science and Technology (SRMIST), hosted Research Day 2026 on April 17, 2026, bringing collectively distinguished leaders from academia, authorities, and {industry} to have a good time excellence in analysis, innovation, and collaboration.
The occasion featured Dr Shivkumar Kalyanaraman, Chief Executive Officer of the Anusandhan National Research Foundation (ANRF), Government of India, because the Chief Guest.
Further strengthening its analysis ecosystem, SRMIST secured ten prestigious grants beneath the ANRF–Prime Minister Early Career Research Grant Scheme, with a cumulative funding of roughly Rs 6.03 crore.
Spanning disciplines resembling chemistry, nanotechnology, physics, medical analysis, and genetic engineering, these initiatives deal with rising areas together with superior supplies, AI-driven analysis, healthcare innovation, and sustainable applied sciences, underscoring the establishment’s rising energy in interdisciplinary and high-impact analysis aligned with nationwide priorities.
Delivering insights on India’s evolving analysis panorama, Dr Shivkumar Kalyanaraman, CEO, Anusandhan National Research Foundation (ANRF), Government of India, outlined the imaginative and prescient of positioning India as a worldwide analysis and innovation powerhouse.
He emphasised that excellence, collaboration, and measurable impression are central to this transformation. Highlighting alternatives via ANRF, together with large-scale funding and industry-linked initiatives, he inspired establishments to deal with high-quality analysis that interprets into societal and financial worth.
Dr P. Sathyanarayanan, Pro-Chancellor (Academics), SRMIST, remarked “SRMIST is ready to launch a state-of-the-art Research Park very quickly, which might be SRM’s dedication to neighborhood, to function a hub for innovation, {industry} collaboration, and translational analysis, whereas bridging the hole between lab discoveries and real-world healthcare options.”